(Total Views: 751)
Posted On: 01/10/2021 5:27:31 AM
Post# of 145874
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
The CD12 results will be good, no doubt...much better than Remdisivir BUT everything is in the hands of the FDA. The FDA is in general always looking or searching for something for a ´non-approval’...so , for Covid, we have to anticipate the best and the worst ...
But Cyto has a very good future, especially with HIV..
They will get an approval for HIV and in the last CC Nader told that a once-monthly injection for monotherapy is possible, ...that’s big, very big...so big that this treatment will change the ´HIV world’ and especially the health from the HIV-patients...and will be very very good for the Cyto shareholders!!
So even with a non-Covid-approval Cyto has a great future..
But Cyto has a very good future, especially with HIV..
They will get an approval for HIV and in the last CC Nader told that a once-monthly injection for monotherapy is possible, ...that’s big, very big...so big that this treatment will change the ´HIV world’ and especially the health from the HIV-patients...and will be very very good for the Cyto shareholders!!
So even with a non-Covid-approval Cyto has a great future..
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)